Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

378 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial.
Eichhorn EJ, Bristow MR. Eichhorn EJ, et al. Among authors: bristow mr. Curr Control Trials Cardiovasc Med. 2001;2(1):20-23. doi: 10.1186/cvm-2-1-020. Curr Control Trials Cardiovasc Med. 2001. PMID: 11806769 Free PMC article.
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.
Yancy CW, Fowler MB, Colucci WS, Gilbert EM, Bristow MR, Cohn JN, Lukas MA, Young ST, Packer M; U.S. Carvedilol Heart Failure Study Group. Yancy CW, et al. Among authors: bristow mr. N Engl J Med. 2001 May 3;344(18):1358-65. doi: 10.1056/NEJM200105033441803. N Engl J Med. 2001. PMID: 11333992 Clinical Trial.
Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Bullinga JR, et al. Among authors: bristow mr. J Card Fail. 2005 Dec;11(9):693-9. doi: 10.1016/j.cardfail.2005.06.435. J Card Fail. 2005. PMID: 16360965 Clinical Trial.
Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy.
Pittenger B, Gill EA, Holcslaw TL, Bristow MR. Pittenger B, et al. Among authors: bristow mr. Am J Cardiol. 2004 Dec 1;94(11):1459-62. doi: 10.1016/j.amjcard.2004.08.021. Am J Cardiol. 2004. PMID: 15566928 Clinical Trial.
Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.
Eichhorn EJ, Bristow MR. Eichhorn EJ, et al. Among authors: bristow mr. Circulation. 1996 Nov 1;94(9):2285-96. doi: 10.1161/01.cir.94.9.2285. Circulation. 1996. PMID: 8901684 Review.
Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study.
Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. Olsen SL, et al. Among authors: bristow mr. J Am Coll Cardiol. 1995 May;25(6):1225-31. doi: 10.1016/0735-1097(95)00012-S. J Am Coll Cardiol. 1995. PMID: 7722114 Clinical Trial.
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.
Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Bristow MR, et al. Circulation. 1996 Dec 1;94(11):2807-16. doi: 10.1161/01.cir.94.11.2807. Circulation. 1996. PMID: 8941106 Clinical Trial.
Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
Quaife RA, Gilbert EM, Christian PE, Datz FL, Mealey PC, Volkman K, Olsen SL, Bristow MR. Quaife RA, et al. Among authors: bristow mr. Am J Cardiol. 1996 Oct 1;78(7):779-84. doi: 10.1016/s0002-9149(96)00420-1. Am J Cardiol. 1996. PMID: 8857482 Clinical Trial.
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes.
Bristow MR, Larrabee P, Müller-Beckmann B, Minobe W, Roden R, Skerl L, Klein J, Handwerger D, Port JD. Bristow MR, et al. Clin Investig. 1992;70 Suppl 1:S105-13. doi: 10.1007/BF00207620. Clin Investig. 1992. PMID: 1350478
Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.
Lowes BD, Gill EA, Abraham WT, Larrain JR, Robertson AD, Bristow MR, Gilbert EM. Lowes BD, et al. Among authors: bristow mr. Am J Cardiol. 1999 Apr 15;83(8):1201-5. doi: 10.1016/s0002-9149(99)00059-4. Am J Cardiol. 1999. PMID: 10215284 Clinical Trial.
This study evaluates the effect of carvedilol on LV mass, geometry, and degree of mitral regurgitation (MR). In 59 patients with symptomatic heart failure and LV ejection fraction <0.35, previously randomized to either treatment with carvedilol or placebo, we evaluated …
This study evaluates the effect of carvedilol on LV mass, geometry, and degree of mitral regurgitation (MR). In 59 patients with symp …
378 results
Jump to page
Feedback